SCHEMBL29695060

SCHEMBL29695060

CSC(=S)OCc1ccc(C(C)(C)O[Si](C)(C)C(C)(C)C)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29694894 0.83 — —
SCHEMBL29695036 0.78 PPARG (0.31) —
SCHEMBL24501299 0.78 PPARG (0.31) —
SCHEMBL38654857 0.77 CYP2C19 (0.38) —
SCHEMBL29108325 0.76 — —
SCHEMBL29108291 0.73 — —
SCHEMBL29574285 0.73 RAB9A (0.45) —
SCHEMBL22717358 0.73 RAB9A (0.45) —
SCHEMBL29108406 0.70 ALDH1A1 (0.33) —
SCHEMBL29108457 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117083271-A Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors 伊迪亚生物科学有限公司 2023-11-17 — — CN disclosed
EP-4255573-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2023-10-11 — — EP disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 — — WO disclosed
Send feedback